Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. - Wikidata - awgldk - TriplyDB

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

http://www.wikidata.org/entity/Q47869308

about

Mechanisms involved in antibody- and complement-mediated allograft rejection Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets What is the best way to measure renal fibrosis?: A pathologist’s perspective Role of complement and NK cells in antibody mediated rejection Late and chronic antibody-mediated rejection: main barrier to long term graft survival The importance of C4d in biopsies of kidney transplant recipients Treatment options and strategies for antibody mediated rejection after renal transplantation Effector mechanisms of rejection Caerulomycin A suppresses immunity by inhibiting T cell activity Antibody-mediated rejection: emergence of animal models to answer clinical questions The Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ Transplantation The Complement System and Antibody-Mediated Transplant Rejection Polymorphisms in CTLA4 influence incidence of drug-induced liver injury after renal transplantation in Chinese recipients Therapeutic apheresis before and after kidney transplantation.Pros and cons for C4d as a biomarker.Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus.Local complement C3 expression is upregulated in humoral and cellular rejection of renal allografts.Thrombotic microangiopathy in the early post-renal transplant period.Current characteristics and outcome of cytomegalovirus infections after kidney transplantation.Diagnosis of c4d+ renal allograft acute humoral rejection by urine protein fingerprint analysis.Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d The evolution of the Banff classification schema for diagnosing renal allograft rejection and its implications for clinicians The role of B cells in solid organ transplantation.Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection.Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.Clinical outcomes among renal transplant recipients with pre-transplant weakly reactive donor-specific antibodies Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery.H-Y antibody development associates with acute rejection in female patients with male kidney transplants Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure.Significance of intragraft CD138+ lymphocytes and p-S6RP in pediatric kidney transplant biopsies.The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria.Immunological challenges of cardiac transplantation: the need for better animal models to answer current clinical questions Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation.Gut microbial community structure and complications after kidney transplantation: a pilot study.Sarcoidosis in native and transplanted kidneys: incidence, pathologic findings, and clinical course.Monocytes/macrophages in kidney allograft intimal arteritis: no association with markers of humoral rejection or with inferior outcome.

P2860

Q24629268-8F58559D-32A9-4607-A0F9-553FE04FEA17 Q26775103-3D4AE00C-41D5-4E01-BC41-A0C7478B96AC Q26796641-AA662085-8EE8-43BC-94E8-EDEFA4851D95 Q26864255-C92B6738-0B30-4A00-95A8-891F85DC0E01 Q27006030-E9791155-7C93-4730-BF28-ECB4D6B8226F Q27021227-2F290333-515C-4A34-9DFE-7D5B769D4811 Q27021397-E22B9BC8-19B4-4F7F-8F96-D85191948CA1 Q27027082-582BA99D-F7E1-4247-9EF1-4314154B254E Q27348735-324B1B4D-74BA-4E83-8D85-008E6C384247 Q27692014-8910E224-3FDB-4672-AA83-183DEF421D61 Q28078919-F267B0D1-782C-4E71-A732-F495B226BCC9 Q28087773-A7004247-8D27-44A7-A3FA-630A0D551D92 Q28484763-7059A218-2B2A-4700-99BE-1703C5970747 Q30454250-5A647938-950B-469D-BD08-75ADB08C91FB Q30544649-DC53BABF-F1E1-448F-A206-1839DB1FB8FB Q30845152-E317C24C-E837-4F70-866B-113DCAD3AE60 Q33214939-01C28C3D-1323-4FE6-B28A-52F43E153AED Q33378757-30B742AD-B482-4F98-B839-95DFF20537DD Q33416126-6C2B1503-D5C3-4395-8ABB-A4B3FB8865F2 Q33541351-28E5B169-19F8-463F-8FF9-837B921461D1 Q33584895-CAE13099-0A69-4761-A541-E7C51D8C8083 Q33822254-6FC084C2-0DBC-4273-8985-F54A3EC371DE Q33884782-335C7996-8E24-4B11-A9B5-57BBE3F32C43 Q33891696-DD9AB981-3D19-427D-A6A5-36A6B55B22AB Q33951763-17DAD4A0-EF39-4DF3-8CCB-CB8BF92902CC Q34004087-B5F5EF38-171E-4C9E-B3A2-C3E8181CAAD1 Q34037420-CBCFB4DE-C004-4073-8CC5-89C4088B6081 Q34080938-D6EFBFEB-3AF0-427C-BAB4-224E50C72F4F Q34122035-95BEADA9-F7DD-4B08-BA4D-BB8B9B40B9FC Q34124202-821F6F75-27A6-4679-A818-E8221FB9F0D4 Q34133012-35E781C9-AAD2-47AF-A09C-AB8960F6B81B Q34147590-88AE874F-FD56-4C62-855F-5E0218F57BAD Q34181871-F7759FD8-5FEA-4E99-8664-98C309CE805C Q34222399-60F98A73-1F83-49DA-88FC-1448F3316DD8 Q34269169-2EEB949D-7D8C-4F77-BBFB-5A044233E6BC Q34289043-1828F65A-F9B6-47BB-BC9D-CDDFB96EB3E9 Q34289498-C31B2AEC-A9FE-4D30-AFF6-EFDC8E875408 Q34307066-1F6FD492-F123-44CD-A0C0-B0E73239B9C7 Q34374430-9015D46F-1085-4C66-843D-53F131339790 Q34381177-A546FE4D-A319-472D-A801-0BBC4F4CD451

P2860

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

http://www.wikidata.org/entity/Q47869308

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Antibody-mediated rejection cr ...... of renal allograft rejection.

@en

Antibody-mediated rejection cr ...... of renal allograft rejection.

@nl

type

label

Antibody-mediated rejection cr ...... of renal allograft rejection.

@en

Antibody-mediated rejection cr ...... of renal allograft rejection.

@nl

prefLabel

Antibody-mediated rejection cr ...... of renal allograft rejection.

@en

Antibody-mediated rejection cr ...... of renal allograft rejection.

@nl

P1433

Q47869308-3D7CDFA5-A97F-4B50-BB5F-11F9E878AC6D

P1476

Q47869308-3C91AC1A-5FDE-475B-8831-8DFD4AE574F0

P2093

Q47869308-0347EEE1-F2B1-49A0-9FA4-EA8DAAADB7C3

Q47869308-14AFFE1E-4AD7-4723-8892-5904D781543D

Q47869308-31FF63C9-536D-4A5C-BF85-47E353B3B599

Q47869308-3A6FCD59-20E8-4CE8-BCDB-6990D6E474A7

Q47869308-3DC6D598-13D3-473F-9C8B-CE3A2927F772

Q47869308-45973D03-EAA8-4FCA-8158-4B71CF6E5A9C

Q47869308-4653FC9F-137E-4A61-B0B1-8C354BDB9CE9

Q47869308-4CF8638D-01C3-4CE9-828B-DCE5E8286665

Q47869308-4F79E39D-B0CE-43CA-8F08-758918CFB3F5

Q47869308-50599C17-5C51-4C73-9D4A-013DA5BCCF40

P2860

Q47869308-100F6A1F-3132-4AA0-A58A-E87E28CFCCA1

Q47869308-4EA2C007-7622-4F0D-8BBB-46B5919F810C

Q47869308-63FDF9ED-AC26-45A6-B922-72F24C6A65FC

Q47869308-798816BB-382A-48D0-A666-68279129B109

Q47869308-936579D0-BCC1-421F-B3E9-0494A992255A

Q47869308-DCEB3495-A8A9-439A-9BC6-D31B1F9C4C32

Q47869308-DF13294A-4DD3-4A18-A006-EE1892B6F7A5

Q47869308-EEF93A59-9609-4641-A65F-F2CBC622D11B

P304

Q47869308-B67F66BA-FCBC-4E2F-9E8D-235FA7D24F07

P31

Q47869308-1A7BF245-9C24-4F90-9A5B-35CE41F95434

P356

Q47869308-44F053BB-C418-4020-B0BE-751DED3E507D

P407

Q47869308-7A6EA3A5-94F7-479C-80F6-C686F29174A0

P433

Q47869308-2139934A-9DFA-437A-ABE1-4B2E350D568B

P478

Q47869308-0285EFBB-5708-4D49-8B9E-64307716A9E0

P50

Q47869308-479319C6-6DD5-4A4A-A5BB-E658671D4924

Q47869308-FF946F21-6FA2-49A3-AB00-06FCBDA5D022

P577

Q47869308-2D7B2CB3-6E1A-4E7B-A874-B6CA9EA4640C

P5875

Q47869308-1B9ADEDD-A5B6-4911-876A-6EC2E63331FC

P698

Q47869308-0DEA0FF2-CDEE-49C0-84F9-C7F0E9665088

P921

Q47869308-3FE7AA57-5F91-41D4-9864-51392E8C3C72

P356

J.1600-6143.2003.00072.X

P1433

American Journal of Transplantation

P1476

Antibody-mediated rejection cr ...... of renal allograft rejection.

@en

P2093

Agnes Fogo

http://www.w3.org/2001/XMLSchema#string

Alex J Magil

http://www.w3.org/2001/XMLSchema#string

Daniel Seron

http://www.w3.org/2001/XMLSchema#string

Denis Glotz

http://www.w3.org/2001/XMLSchema#string

Heinz Regele

http://www.w3.org/2001/XMLSchema#string

Ian W Gibson

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Cosyns

http://www.w3.org/2001/XMLSchema#string

Kim Solez

http://www.w3.org/2001/XMLSchema#string

Kiril Trpkov

http://www.w3.org/2001/XMLSchema#string

Kunio Morozumi

http://www.w3.org/2001/XMLSchema#string

P2860

Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection.

Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes.

Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection.

Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

Tortuosity of the white matter medullary arterioles is related to the severity of hypertension.

Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

The Banff 97 working classification of renal allograft pathology

P304

708-714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1600-6143.2003.00072.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Philip F Halloran

Anthony J. Demetris

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10730111

http://www.w3.org/2001/XMLSchema#string

P698

12780562

http://www.w3.org/2001/XMLSchema#string

P921